Infection
Breakthrough in Paratyphoid Fever Vaccine: Oxford-led Study Shows 73% Efficacy in Healthy Adults
A groundbreaking study published in The New England Journal of Medicine has demonstrated the efficacy of a vaccine against Salmonella Paratyphi A infection, a major contributor to enteric fever that causes over 100,000 deaths and 8 million disability-adjusted life years annually. The Oxford-led research used a controlled human infection